Pending Home Sales Near 12-Year Low as Mortgage Rates Top 7%; Rocket's Recovery Thesis Faces Setback

What happened

U.S. pending home sales fell to their lowest level since 2014 as 30-year mortgage rates climbed above 7%, signaling a further deterioration in housing affordability and demand. This data point directly contradicts the recent narrative that rates near 6% would spark a refinance and purchase recovery for Rocket Companies. Rocket's own filings acknowledged that even at 6.15% rates, affordability remained elevated and weighed on origination activity. With rates now back above 7%, both purchase and refinance volumes are likely to remain depressed, undermining the company's volume growth assumptions. The news also raises the risk of MSR fair-value volatility, as the large servicing portfolio is highly sensitive to interest rate movements.

Implication

The housing market's deteriorating leading indicator and elevated mortgage rates directly challenge Rocket's ability to grow lock volume, which could compress gain-on-sale revenue and contribute margin. Rocket's $19.4 billion MSR portfolio faces increased mark-to-market risk as rising rates may reduce the fair value of servicing rights despite slower prepayments. The company's paid distribution strategy with Compass and Redfin may yield less incremental purchase volume if overall homebuying remains subdued. With an EV/EBITDA near 50x and negative free cash flow, the stock's valuation is built on aggressive recovery assumptions that now appear less credible. Investors should wait for evidence of stabilizing housing data and controlled MSR volatility before considering an entry near the current price, with the more attractive entry point likely closer to $14.

Thesis delta

The thesis shifts from expecting a rate-driven refinance recovery to acknowledging a renewed housing downturn with mortgage rates above 7%. The prior base case assumed rates near 6% would sustain elevated refinance activity, but this macro data reduces the probability of that outcome and increases the bear case likelihood. We lower our base case implied value from $17 to approximately $14-$15 and would only become constructive on evidence of housing stabilization and controlled MSR marks.